Amiodarone-induced pulmonary toxicity in fischer rats: Release of tumor necrosis factor alpha and transforming growth factor beta by pulmonary alveolar macrophages

Journal of Toxicology and Environmental Health

Volumn 52, Issue 4, 1997, Pages 353-365

  Reinhart, Paul G ^a   Gairola, C Gary ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b University of Kentucky   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; CYTOKINE; DEETHYLAMIODARONE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; FEMALE; INTRATRACHEAL DRUG ADMINISTRATION; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROSIS; LUNG LAVAGE; LUNG TOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

AMIODARONE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; MACROPHAGES, ALVEOLAR; PULMONARY ALVEOLI; RATS; RATS, INBRED F344; TRACHEA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 0030714658     PISSN: 00984108     EISSN: None     Source Type: Journal    
DOI: 10.1080/00984109708984070     Document Type: Article

References (32)

1. Akoun, C. M., Liote, G., Milleron, B. J., and Mayaud, C. M. 1987. Amiodarone lung. In Current topics in pulmonary pharmacology and toxicology, ed. M. A. Hollinger, pp. 176-194. New York: Elsevier.
2. Beddows, S. A., Page, S. R., Taylor, A. H., McNerney, R., Withley, G. St. J., Johnstone, A. P., and Nussey, S. S. 1989. Cytotoxic effects of amiodarone and desethylamiodarone on human thyrocytes. Biochem. Pharmacol. 38:4397-4403.
3. Danielpour, D., Dart, L. L., Flanders, K. C., Roberts, A. B., and Sporn, M. B. 1989. Immunodetection and quantification of the two forms of transforming growth factor-beta (TGF-p1 and TGF-P2) secreted by cells in culture. J. Cell. Physiol. 138:79-86.
4. Daniels, J. M., Brien, J. F., and Massey, T. E. 1989. Pulmonary fibrosis induced in the hamster by amiodarone and desethylamiodarone. Toxicol. Appl. Pharmacol. 100:350-359.
5. 2 production by human synovial cells and dermal fibroblasts. J. Exp. Med. 162:2163-2168.
6. Cross, S. A., Bandyopadhyay, S., Klaunig, J. E., and Somani, P. 1989. Amiodarone and desethy-lamiodarone toxicity in isolated hepatocytes in culture. Proc. Soc. Exp. Biol. Med. 190:163-169.
7. Hajjar, K. A., Hajjar, D. P., Silverstein, R. L., and Nachman, R. L. 1987. Tumor necrosis factor-mediated release of platelet-derived growth factor from cultured endothelial cells. J. Exp. Med. 166:235-245.
8. Hoyt, D. G., and Lazo, J. S. 1988a. Alterations in pulmonary mRNA encoding procollagens, fibronectin and transforming growth factor-P precede bleomycin-induced pulmonary fibrosis in mice. J. Pharmacol. Exp. Ther. 246:765-771.
9. Hoyt, D. G., and Lazo, J. S. 1988b. Early increases in pulmonary mRNA encoding procollagens and transforming growth factor-p in mice sensitive to cyclophosphamide-induced pulmonary fibrosis. J. Pharmacol. Exp. Ther. 249:38-43.
10. Ignotz, R. A., and Massague, J. 1986. Transforming growth factor-p stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem. 261:4337-4345.
11. Israel-Biet, D., Venet, A., Caubarrere, I., Bonan, G., Danel, C., Chretien, J., and Hance, A. J. 1987. Bronchoalveolar lavage in amiodarone pneumonitis: Cellular abnormalities and their relevance to pathogenesis. Chest 91:214-221.
12. 2-interferon by tumor necrosis factor: A homeostatic mechanism in the control of cell proliferation. Cell 45:659-666.
13. Kramer, S. M., and Carver, M. E. 1986. Serum-free in vitro bioassay for the detection of tumor necrosis factor. J. Immunol. Methods 93:201-206.
14. Le, J., Weinstein, D., Gubler, U., and Vilcek, J. 1987. Induction of membrane-associated interleukin 1 by tumor necrosis factor in human fibroblasts. J. Immunol. 138:2137-2142.
15. Martin, W. J. II, and Rosenow, E. C. III. 1988. Amiodarone pulmonary toxicity. Recognition and pathogenesis. Chest 93:1067-1075.
16. Matsushima, K., Morishita, K., and Yoshimura, T., Lavu, Sukadev, Kobayashi, Y., Lew, W., Appella, E., Kung, H. S., Leonard, E. J., and Oppenheim, J. J. 1988. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin-1 and tumor necrosis factor. J. Exp. Med. 167:1883-1893.
17. Nawroth, P. P., Bank, I., Handley, D., Cassimeris, J., Chess, L., and Stern, D. 1986. Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1. J. Exp. Med. 163:1363-1375.
18. Ogle, C. L., and Reasor, M. J. 1990. Response of alveolar macrophages to amiodarone and desethylamiodarone, in vitro. Toxicology 62:227-238.
19. Penttinen, R. P., Kobayashi, S., and Bornstein, P. 1988. Transforming growth factor p increases mRNA for matrix proteins both in the presence and absence of changes in mRNA stability. Proc. Natl. Acad. Sci. USA 85:1105-1108.
20. Phan, S. H., and Kunkel, S. L. 1992. Lung cytokine production in bleomycin-induced pulmonary fibrosis. Exp. Lung Res. 18:29-43.
21. Piguet, P. F., Collart, M. A., Grau, G. E., Kapanci, Y., and Vassalli, P. 1989. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J. Exp. Med. 170:655-663.
22. Pober, J. S., Bevilacqua, M. P., Mendrick, D. L., Lapierre, L. A., Fiers, W., and Gimbrone, M. A. 1986. Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells. J. Immunol. 136:1680-1687.
23. Reasor, M. J., and Kacew, S. 1990. Amiodarone pulmonary toxicity: Morphologic and biochemical features. Proc. Soc. Exp. Biol. Med. 196:1-7.
24. Reasor, M. J., and Kacew, S. 1996. An evaluation of possible mechanisms underlying amio-darone-induced pulmonary toxicity. Proc. Soc. Exp. Biol. Med. 212:297-304.
25. Reasor, M. J., Ogle, C. L., and Kacew, S. 1989. Amiodarone-induced pulmonary toxicity in rats: Biochemical and pharmacological characteristics. Toxicol. Appl. Pharmacol. 97:124-133.
26. Reasor, M. J., McCloud, C. M., DiMatteo, M., Schafer, R., Ima, A., and Lemaire, I. 1996. Effects of amiodarone-induced phospholipidosis on pulmonary host defense functions in rats. Proc. Soc. Exp. Biol. Med. 211:346-352.
27. Reinhart, P. G., Lai, Y.-L., and Gairola, C. G. 1996. Amiodarone-induced pulmonary fibrosis in Fischer 344 rats. Toxicology 110:95-101.
28. Roberts, A. B., and Sporn, M. B. 1990. The transforming growth factor betas. In Peptide growth factors and their receptors. Handbook of experimental pharmacology, eds. M. B. Sporn and A. B. Roberts, pp. 419-472. New York: Springer-Verlag.
29. Venet, A., Caubarrere, I., and Bonan, C. 1984. Five cases of immune-mediated amiodarone pneumonitis. Lancet 1:962-963.
30. Vilcek, J., Palombella, V. J., Henriksen-DeStefano, D., Swenson, C., Feinman, R., Hirai, M., and Tsujimoto, M. 1986. Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors. J. Exp. Med. 163:632-643.
31. Wilson, B. D., and Lippmann, M. L. 1990. Pulmonary accumulation of amiodarone and N-desethylamiodarone. Relationship to the development of pulmonary toxicity. Am. Rev. Respir. Dis. 141:1553-1558.
32. Wilson, B. D., Clarkson, C. E., and Lippmann, M. L. 1991. Amiodarone-induced pulmonary inflammation: Correlation with drug dose and lung levels of drug, metabolite, and phospholipid. Am. Rev. Respir. Dis. 143:1110-1114